Spyryx Biosciences
  • PIPELINE
  • TRIALS
  • Science
    • SPX-101
    • PUBLICATIONS
  • team
    • LEADERSHIP
    • BOARD OF DIRECTORS
  • PRESS
  • COMMUNITY
    • EVENTS
    • VOICES
  • Contact

News : Latest News, Press Releases & Events

home1-banner1.jpg

  • March 30, 2017

Related

Categories

  • In The News
  • Press Release
  • Publications

Recent News & Events

  • SPX-101 is Stable In and Retains Function After Exposure to Cystic Fibrosis Sputum July 18, 2018
  • Phase 2 Study Shows Promising Results for Potential Mucus Clearance Drug June 8, 2018
  • Spyryx SPX-101 Phase 2 HOPE-1 Trial Shows Improvement in Lung Function in Patients with Cystic Fibrosis via Novel Modulation of ENaC June 6, 2018
  • Data from Spyryx Biosciences’ HOPE-1 Phase 2 Clinical Trial to be Presented in a Late-Breaking Oral Presentation at the 41st European Cystic Fibrosis Conference May 8, 2018
  • Spyryx Biosciences Expands with Election of Roger Jeffs, PhD as Independent Director January 16, 2018
  • Positive Pre-Clinical Data Supporting SPX-101 to be Presented at the North American Cystic Fibrosis Conference November 1, 2017

Archives

  • July 2018
  • June 2018
  • May 2018
  • January 2018
  • November 2017
  • October 2017
  • June 2017
  • May 2017
  • March 2017
  • February 2017
  • November 2016
  • October 2016
  • August 2016
  • August 2015
  • June 2015

LOCATION
801-10 CAPITOLA DRIVE 
DURHAM, NC 27713
919.899.9399
PIPELINE
PIPELINE
CLINICAL TRIALS
CONTACT
contact@spyryxbio.com
Copyright ® 2018 Spyryx Biosciences, Inc.
All Rights Reserved.

Related